These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 8632998

  • 1. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
    Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S.
    Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):3963-6. PubMed ID: 8632998
    [Abstract] [Full Text] [Related]

  • 2. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells.
    Tanuma N, Nakamura K, Shima H, Kikuchi K.
    J Biol Chem; 2000 Sep 08; 275(36):28216-21. PubMed ID: 10859312
    [Abstract] [Full Text] [Related]

  • 3. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP, Hocke GM.
    Cytokine; 1997 Sep 08; 9(9):639-49. PubMed ID: 9325012
    [Abstract] [Full Text] [Related]

  • 4. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
    Park JI, Strock CJ, Ball DW, Nelkin BD.
    Mol Cell Biol; 2003 Jan 08; 23(2):543-54. PubMed ID: 12509453
    [Abstract] [Full Text] [Related]

  • 5. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
    Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, Kishimoto T.
    Circulation; 1996 Nov 15; 94(10):2626-32. PubMed ID: 8921810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
    Suzuki R, Sakamoto H, Yasukawa H, Masuhara M, Wakioka T, Sasaki A, Yuge K, Komiya S, Inoue A, Yoshimura A.
    Oncogene; 1998 Oct 29; 17(17):2271-8. PubMed ID: 9811457
    [Abstract] [Full Text] [Related]

  • 9. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 29; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 10. Leukemia inhibitory factor enhances mast cell growth in a mast cell/fibroblast co-culture system through stat3 signaling pathway of fibroblasts.
    Hiragun T, Morita E, Mihara S, Tanaka T, Gyotoku E, Kameyoshi Y, Yamamoto S.
    FEBS Lett; 2000 Dec 29; 487(2):219-23. PubMed ID: 11150513
    [Abstract] [Full Text] [Related]

  • 11. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.
    FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
    Park JI, Strock CJ, Ball DW, Nelkin BD.
    Cytokine; 2005 Feb 07; 29(3):125-34. PubMed ID: 15613280
    [Abstract] [Full Text] [Related]

  • 13. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
    Bellido T, Borba VZ, Roberson P, Manolagas SC.
    Endocrinology; 1997 Sep 07; 138(9):3666-76. PubMed ID: 9275051
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):198-206. PubMed ID: 11038252
    [Abstract] [Full Text] [Related]

  • 17. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 18. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.
    Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K, Kishimoto T.
    J Clin Invest; 1997 Jun 15; 99(12):2898-905. PubMed ID: 9185513
    [Abstract] [Full Text] [Related]

  • 19. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H.
    Circulation; 2003 Feb 18; 107(6):798-802. PubMed ID: 12591746
    [Abstract] [Full Text] [Related]

  • 20. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T.
    Nature; 1997 Jun 26; 387(6636):924-9. PubMed ID: 9202127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.